Best for 0% commission stocks
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Fractional shares
Get dividend payments
Vivos Therapeutics Inc (VVOS) is a publicly traded medical devices business based in the US which employs around 100 staff. Vivos Therapeutics is listed on the NASDAQ and traded in US dollars. Its current price of $2.28 is 15.9% down on its price a month ago ($2.71).
How to buy shares in Vivos Therapeutics
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. To trade US shares you'll need to complete a W8-BEN form – typically part of the sign-up process.
- Fund your account. Add money to your account via bank transfer or debit card.
- Search the platform by ticker symbol. VVOS in this case.
- Choose an order type. Place a market order (or limit order, if you want to try to hold out for a specific price) with your preferred number of shares or investment amount.
- Submit the order. It's that simple.
Our top picks for where to buy Vivos Therapeutics shares
Best for uninvested cash
Capital at risk. T&Cs apply.
Up to 8.5% interest on uninvested cash
11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools
Commission-free investing
Advanced trading tools
Best for fractional shares
Capital at risk. T&Cs apply.
Earn 4.5% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Fractional shares
5,400+ stocks/ETFs
Vivos Therapeutics stock chart
Use our graph to track the performance of VVOS stock over time.Fees calculator for buying Vivos Therapeutics shares with popular apps
Find the cheapest way to buy Vivos Therapeutics shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).
Quantity of shares
1000
| Platform | Finder Score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
|
9
Excellent
|
£0 | $100 | £1,720.07 |
Go to siteCapital at risk
|
 |
9.1
Excellent
|
£0 | £0 | £1,724.17 |
Go to siteCapital at risk
|
|
9
Excellent
|
From £0 | £0 | £1,719.21 |
Go to siteCapital at risk
|
 |
8.8
Great
|
£0 | £0 | £1,707.78 |
Go to siteCapital at risk
|
|
9.2
Excellent
|
£0 | £0 | £1,715.80 |
Go to siteCapital at risk
|
 |
8.5
Great
|
£0 (0.45% for funds) | £1 | £1,736.29 |
Go to siteCapital at risk
|
Full comparison of share dealing platforms
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Vivos Therapeutics stock?
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
Technical analysis
View Vivos Therapeutics's price performance, share price volatility, historical data and technicals.
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Historical closes compared with the last close of $2.28
| 1 week (2025-05-15) | -10.24% |
|---|---|
| 1 month (2025-04-23) | -15.87% |
| 3 months (2025-02-23) | -34.10% |
| 6 months (2024-11-21) | -28.75% |
| 1 year (2024-05-23) | 8.57% |
| 2 years (2023-05-23) | -77.54% |
| 3 years (2022-05-23) | -93.71% |
| 5 years (2020-05-17) |
Invest in Vivos Therapeutics shares
Finder AwardFree Trades
- Over 5,500+ stocks from 20 exchanges
- Free to open an account
- Commission-free trading
Go to site
Capital at risk
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Frequently asked questions
Ready to compare platforms?More resources on Finder
More guides on Finder
-
Best stock brokers in the UK
Search our directory of UK stock brokers partnered with the London Stock Exchange (LSE) and learn about how each of them operates.
-
InvestEngine promo codes for 2025
See if you can make your investment go even further with free-share, cashback or refer-a-friend offers from InvestEngine. Here’s what’s live right now.
-
Lightyear promo codes for 2025
See if you can make your money go further with free-share, cashback or refer-a-friend offers from Lightyear. Here’s what’s live right now.
-
Trading 212 promo codes for 2025
See if you can make your money go further with free-share, cashback or refer-a-friend offers from Trading 212. Here’s what’s live right now.
-
Best investment platforms paying high interest on cash
Some trading apps and platforms now offer competitive interest rates on uninvested cash.
-
Best trading apps in the UK (2025)
We’ve tested, analysed and scored trading apps to find the 10 best trading apps in the UK, who they’re best for and the pros and cons.
-
Best trading apps for beginners
We’ve reviewed the best online trading platforms in the UK and explained why they’re best suited to beginners, with pros and cons.
-
Best junior stocks and shares ISAs
A junior stocks and shares ISA account (JISA) is a tax-efficient way to save for your child’s future, here are the best options and how to compare.
-
Best stocks and shares ISA in the UK for 2025
We’ve reviewed the best stocks and shares ISA accounts in the UK, explaining who they might suit and what the benefits and drawbacks are.
-
Best investment trusts for 2025
We’ve put together a list of the best investment trusts of recent times, in terms of performance, income generation and popularity.